Journal of Critical Care
Volume 25, Issue 2 , Pages 276-281 , June 2010

Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock

  • Arturo Artero, MD,PhD

      Affiliations

    • Department of Internal Medicine, Hospital Universitario Dr Peset Av Gaspar Aguilar 90, 46017 Valencia, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 961622457; fax: +34 961622301.
    • ,
  • Rafael Zaragoza, MD

      Affiliations

    • Intensive Care Unit, Hospital Universitario Dr Peset Valencia, 46017 Valencia, Spain
    • ,
  • Juan J. Camarena, MD,PhD

      Affiliations

    • Department of Microbiology, Hospital Universitario Dr Peset Valencia, 46017 Valencia, Spain
    • ,
  • Susana Sancho, MD,PhD

      Affiliations

    • Intensive Care Unit, Hospital Universitario Dr Peset Valencia, 46017 Valencia, Spain
    • ,
  • Rosa González

      Affiliations

    • Department of Microbiology, Hospital Universitario Dr Peset Valencia, 46017 Valencia, Spain
    • ,
  • José M. Nogueira, MD,PhD

      Affiliations

    • Department of Microbiology, Hospital Universitario Dr Peset Valencia, 46017 Valencia, Spain

References 

  1. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005;365:63–78
  2. Annane D, Aegerter P, Jars-Guincestre MC, et al. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med. 2003;1687:165–172
  3. Cunha BA. Sepsis and septic shock: selection of empiric antimicrobial therapy. Crit Care Clin. 2008;24:313–314
  4. Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). JAMA. 1995;273:117–123
  5. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–1554
  6. Crowe M, Ispahani P, Humphreys H, et al. Bacteremia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985-1996. Eur J Clin Microbiol Infect Dis. 1998;17:377–384
  7. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146–155
  8. Zaragoza R, Artero A, Camarena JJ, et al. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect. 2003;9:1–7
  9. Hugonnet S, Harbarth S, Ferrière K, et al. Bacteremic sepsis in intensive care: temporal trends in incidence, organ dysfunction, and prognosis. Crit Care Med. 2003;31:390–394
  10. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004;30:536–555
  11. Ferrer R, Artigas A, Levy MM, et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA. 2008;299:2294–2303
  12. Talan DA, Moran GJ, Abrahamian FM. Severe sepsis and septic shock in the emergency department. Infect Dis Clin North Am. 2008;22:1–31
  13. Vallés J, Rello J, Ochagavía A, et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest. 2003;123:1615–1624
  14. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections. A risk factor of hospital mortality among critically ill patients. Chest. 1999;115:462–474
  15. Garnacho-Montero J, Ortiz-Leyva C, Herrera-Melero I, et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother. 2008;61:436–441
  16. Leibovici L, Shraga I, Drucker M, et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med. 1998;244:379–386
  17. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–474
  18. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742–2751
  19. American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee. Definition for sepsis and organ failures and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644–1655
  20. McCabe WR, Jackson GG. Gram negative bacteremia. Arch Intern Med. 1962;110:92–100
  21. Laupland KB, Gregson DB, Zygun DA, et al. Severe bloodstream infections: a population-based assessment. Crit Care Med. 2004;32:992–997
  22. Bone RC, Fisher CJ, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317:653–658
  23. Rello J, Ricart M, Mirelis B, et al. Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med. 1994;20:94–98
  24. Pittet D, Thievent B, Wenzel RP, et al. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med. 1996;153:684–693
  25. Vallés J, León C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis. 1997;24:387–395
  26. Wallace SM, Walton BI, Kharbanda RK, et al. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88:53–60
  27. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidedemiol. 1997;50:693–703
  28. Beck DH, Taylor BL, Millar B, et al. Prediction of outcome from intensive care: a prospective cohort study comparing Acute Physiology and Chronic Health Evaluation II and III prognostic systems in a United Kingdom intensive care unit. Crit Care Med. 1997;25:9–15
  29. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–797
  30. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–1596
  31. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377

☆ Institution at which the work was performed: Hospital Universitario Dr Peset Av Gaspar Aguilar 90, 46017 Valencia, Spain.

☆☆ No conflicts of interest to disclose.

PII: S0883-9441(10)00004-3

doi: 10.1016/j.jcrc.2009.12.004

Journal of Critical Care
Volume 25, Issue 2 , Pages 276-281 , June 2010

Article Tools